The Sorafenib Plus Nutlin-3 Combination Promotes Synergistic Cytotoxicity in Acute Myeloid Leukemic Cells Irrespectively of FLT3 and P53 Status

Haematologica - Italy
doi 10.3324/haematol.2012.062083
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

A Novel Combination Therapy Approach for the Treatment of Acute Myeloid Leukemia: The Multi-Kinase Inhibitor Sorafenib and the HDM2 Inhibitor Nutlin-3

Haematologica
Hematology
2012English

mTOR Signaling Is Activated by FLT3 Kinase and Promotes Survival of FLT3-mutated Acute Myeloid Leukemia Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

MYC Inhibition Plus P53 Stabilization Targets Leukemic Stem Cells

Cancer Discovery
Oncology
2016English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

Correlation Analysis of P53 Protein Isoforms With NPM1/FLT3 Mutations and Therapy Response in Acute Myeloid Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Nutlin-3 Enhances the Bortezomib Sensitivity of P53-Defective Cancer Cells by Inducing Paraptosis

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2017English

Examination of the FLT3 and NPM1 Mutational Status in Patients With Acute Myeloid Leukemia From Southeastern Poland

Archives of Medical Science
Medicine
2016English

Synergistic Cell Death in FLT3-ITD Positive Acute Myeloid Leukemia by Combined Treatment With Metformin and 6-Benzylthioinosine

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy